Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details)

v3.23.1
SUMMARIZED FINANCIAL INFORMATION FOR PARTLY OWNED SUBSIDIARY - Disclosure of operating results for partly owned subsidiary (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]      
Revenues $ 54,335 $ 34,053 [1] $ 15,890
Net loss (191,301) (18,518) [1] (28,734)
Other comprehensive income (1,425) 1,409 [1] 990
Total comprehensive loss (192,726) (17,109) [1] $ (27,744)
Focus Medical Herbs Ltd [Member]      
Disclosure Of Summarized Financial Information For Partly Owned Subsidiary [Line Items]      
Revenues 19,565 14,747  
Net loss (7,746) (1,524)  
Other comprehensive income 96 37  
Total comprehensive loss $ (7,650) $ (1,487)  
[1] Reclassified in respect of discontinued operations - see Note 24.